Compounds > myelopeptide 1
Page last updated: 2024-09-03

myelopeptide 1 and Pneumonia

myelopeptide 1 has been researched along with Pneumonia in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (66.67)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abbakumov, VV; Bogomolova, NS; Pkhakadze, TIa; Potekhina, AD; Stepanenko, RN; Vinogradova, LN1
Khabarov, AS; Kolesnikov, AP; Kozlov, VA1
Borisova, AM; Glazko, AV; Petrov, RV; Simonova, AV; Stepanenko, RN1

Other Studies

3 other study(ies) available for myelopeptide 1 and Pneumonia

ArticleYear
[Current approaches to the prevention of infectious complications in heart surgery].
    Khirurgiia, 1993, Issue:2

    Topics: Activins; Adjuvants, Immunologic; Adolescent; Adult; B-Lymphocytes; Bacterial Infections; Cefotaxime; Extracorporeal Circulation; Heart Valve Diseases; Humans; Intraoperative Complications; Middle Aged; Oligopeptides; Peptides; Pneumonia; Postoperative Care; Rheumatic Heart Disease; Risk Factors; Surgical Wound Infection; T-Lymphocytes

1993
[Diagnosis and differentiated treatment of secondary immunodeficiencies].
    Terapevticheskii arkhiv, 2001, Volume: 73, Issue:4

    Topics: Acute Disease; Adjuvants, Immunologic; Antibody Formation; Biomarkers; Bronchitis; Chronic Disease; Cytokines; Drug Combinations; Fluorescent Antibody Technique, Indirect; Homeostasis; Humans; Immunity, Cellular; Immunocompromised Host; Immunoglobulins; Immunologic Deficiency Syndromes; Immunologic Factors; Infections; Inflammation; Interferon Type I; Oligopeptides; Phagocyte Bactericidal Dysfunction; Phagocytes; Pneumonia; Recurrence; Rosette Formation; Shock, Septic; Suppuration; T-Lymphocytes; Time Factors; Virus Diseases

2001
[Efficacy of myelopid in immunodeficiency states].
    Terapevticheskii arkhiv, 1990, Volume: 62, Issue:12

    Topics: Activins; Adjuvants, Immunologic; Adolescent; Adult; Agammaglobulinemia; B-Lymphocytes; Bronchitis; Chronic Disease; Female; Humans; Immune Tolerance; Leukocyte Count; Middle Aged; Multiple Sclerosis; Oligopeptides; Peptides; Pneumonia; Remission Induction; T-Lymphocytes

1990